Novacyt « Terug naar discussie overzicht

Novacyt de volgende biotech raket!

snowhmr
1
quote:

DeZwarteRidder schreef op 16 februari 2021 14:48:

[...]

Een beetje erg laat, hè..........!!
Zou dit de eerste keer zijn dat je het goed hebt qua nova?
Ik ben het er mee eens, als ze met een sneltest komen kan de koek best wel eens op zijn. Of Nova moet denken dat er nog markt is in de USA voor sneltesten.
[verwijderd]
0
www.proactiveinvestors.co.uk/companie...

"COVID-19 tests are here to stay even though the vaccine rollout is continuing at pace, while some experts reckon the diagnostics market has yet to peak"

16 Feb 2021

Novacyt wordt er in vermeld
Puli
1
Warren Buffett zei : "De beurs is een mechanisme dat geld overmaakt ...van de ongeduldigen naar de geduldigen "
Geduld dus....maar GM, aub laat ons niet zo lijden en spreek !!
[verwijderd]
1
quote:

John P. schreef op 16 februari 2021 16:16:

www.proactiveinvestors.co.uk/companie...

"COVID-19 tests are here to stay even though the vaccine rollout is continuing at pace, while some experts reckon the diagnostics market has yet to peak"

16 Feb 2021

Novacyt wordt er in vermeld
To effectively help control the pandemic in the UK alone, it has been suggested the government will need around 120mln tests per month.

Proof of negative results is already required for international travel – all passengers to the UK must take a test three days before departure then take another two on days 2 and 8 of the 10-day quarantine once arrived.

Companies offering or developing PCR tests include Novacyt SA (LON:NCYT), Yourgene Health PLC (LON:YGEN) and genedrive PLC (LON:GDR).

Mooi dat ze erbij staan.
Tommaco
1
quote:

Puli schreef op 16 februari 2021 15:51:

bidstats.uk/tenders/2021/W07/745013583

Jammer is dit NIET Novacyd.. £728M (InnovaMedicalGroup)
SARS-CoV-2 Antigen Rapid Qualitative Test Kits
A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE
Source
Find a Tender
Type
Contract (Goods)
Duration
not specified
Value
£728M
Sector
HEALTH
Published
15 Feb 2021
Delivery
not specified
Deadline
n/a

Pff hebben ze nu nog rommel van Innova gekocht.
Tommaco
0
quote:

Hercule Poirot schreef op 16 februari 2021 16:18:

[...]
To effectively help control the pandemic in the UK alone, it has been suggested the government will need around 120mln tests per month.

Proof of negative results is already required for international travel – all passengers to the UK must take a test three days before departure then take another two on days 2 and 8 of the 10-day quarantine once arrived.

Companies offering or developing PCR tests include Novacyt SA (LON:NCYT), Yourgene Health PLC (LON:YGEN) and genedrive PLC (LON:GDR).

Mooi dat ze erbij staan.
Mooi, alle 3 in portefeuille :) En onderaan ook nog ODX.
DeZwarteRidder
0
quote:

Hercule Poirot schreef op 16 februari 2021 16:18:

[...]
To effectively help control the pandemic in the UK alone, it has been suggested the government will need around 120mln tests per month.

Proof of negative results is already required for international travel – all passengers to the UK must take a test three days before departure then take another two on days 2 and 8 of the 10-day quarantine once arrived.

Companies offering or developing PCR tests include Novacyt SA (LON:NCYT), Yourgene Health PLC (LON:YGEN) and genedrive PLC (LON:GDR).

Mooi dat ze erbij staan.
De toekomst is aan de goedkope sneltesten.
[verwijderd]
1
quote:

DeZwarteRidder schreef op 16 februari 2021 16:30:

[...]

De toekomst is aan de goedkope sneltesten.
Voor het testen van de massa, ja.
Voor het testen van plekken waar je die 20% false negatives niet wil, nee.
Speculatie
0
Onderaan de streep heb je minder PCRs nodig qua aantallen tov die sneltesten. Ik krijg ook het idee dat Novacyt aan de prijs is.
[verwijderd]
0
Als nova al vanaf het begin naam heeft gemaakt in de testwereld, dan ga ik er een klein beetje vanuit dat de opgebouwde reputatie wat meer mag kosten?

En nee dit is geen roze brillen gedachte van mij.
Ik heb het zelf ook met enkele merken. Samsung heeft mij nog nooit teleurgesteld qua mobiele telefoon en daarom heb ik al meer dan 10 jaar Samsung telefoons.
Speculatie
0
Er is toch heel veel geld uitgegeven door overheden aan veel goedkopere testkits (China). Inkopers gaan blijkbaar meer op prijs dan kwaliteit. Daarnaast begrijpen ze ook heus wel dat PrimerDesign flinke marges heeft.

Maar goed, de koers spreekt voor zich
HaBe
0
quote:

Tommaco schreef op 16 februari 2021 16:28:

[...]

Pff hebben ze nu nog rommel van Innova gekocht.
Weet iemand wat de gevolgen zijn voor Novacyt? Ik zou graag willen weten of er meerdere grote tenders zijn waar wat uit kan komen.
[verwijderd]
1
quote:

HaBe schreef op 16 februari 2021 16:58:

[...] Weet iemand wat de gevolgen zijn voor Novacyt? Ik zou graag willen weten of er meerdere grote tenders zijn waar wat uit kan komen.
Er is een hele grote pot voor test & trace.
[verwijderd]
0
quote:

HaBe schreef op 16 februari 2021 16:58:

[...] Ik zou graag willen weten of er meerdere grote tenders zijn waar wat uit kan komen.
Moet je ff bidstats.uk/ in de gaten houden.
HaBe
0
quote:

N13k schreef op 16 februari 2021 17:15:

[...]

Moet je ff bidstats.uk/ in de gaten houden.
Dank je, ik ben er nog niet zo in thuis en ga eens ff kijken.
€URO-Trader
0
quote:

DeZwarteRidder schreef op 16 februari 2021 16:30:

[...]

De toekomst is aan de goedkope sneltesten.
en niet adequate.
Puli
0
www.proactiveinvestors.co.uk/companie...

Health
Giulia Bottaro
12:35 Tue 16 Feb 2021

viewNovacyt SACOVID-19 tests may become more frequent as Boris Johnson suggests rapid assays to open nightclubs

The diagnostics market has yet to peak, according to a broker

COVID-19 tests are here to stay even though the vaccine rollout is continuing at pace, while some experts reckon the diagnostics market has yet to peak.

Boris Johnson suggested rapid lateral flow assays could be used to support businesses that have been shuttered for nearly a year, such as nightclubs and theatres.

"That, in combination with vaccination, will probably be the route forward," he said at a press conference, although he noted it is still “early days", with "lots of discussions still to be had".

"There is a long way to go before we can get people back at big events safely,” a government source told the BBC.

Diagnostics firms touched record highs at the onset of the pandemic last year but rallies were dampened once vaccines started being approved and rolled out.

Many bounced back when it became clear tests will be needed for many months ahead until the virus is curbed.

Herd immunity would require 60-70% of the global population to be immune, which is around 5bn people.

To effectively help control the pandemic in the UK alone, it has been suggested the government will need around 120mln tests per month.

Proof of negative results is already required for international travel – all passengers to the UK must take a test three days before departure then take another two on days 2 and 8 of the 10-day quarantine once arrived.   

Companies offering or developing PCR tests include Novacyt SA (LON:NCYT), Yourgene Health PLC (LON:YGEN) and genedrive PLC (LON:GDR).

genedrive recently announced partner Beckman Coulter Life Sciences will sell its testing technology in the US, opening a new sales channel.

The automated solution can process 1,000 PCR samples per workstation over a standard eight-hour day, requiring in the process the equivalent of just half a full-time technician.

PCR testing is the most common type of testing as it provided the highest levels of accuracy, but is expensive and requires experienced professionals and some results can take days to process.

Lateral flow diagnostics, although not always as accurate as other technologies, can provide cheap and rapid results and be administered without training.

Companies offering or developing COVID-19 lateral flow tests (LFT) include Avacta Group PLC (LON:AVCT), Omega Diagnostics Group PLC (LON:ODX), Abingdon Health plc (LON:ABDX) and Immunodiagnostic Systems Holdings PLC (LON:IDH).

Braveheart Investment Group PLC’s (LON:BRH) investee company Paraytec is working with Sheffield University on a fast tool as well.

Meanwhile, Sensyne Health PLC (LON:SENS) is providing its MagnifEye system to LFT producer Excalibur Healthcare Services.

MagnifEye is an AI-powered software to read test results on smartphones; its algorithm detects lines that are difficult to read, including those not visible to the human eye, with the goal to improve accuracy.

“The encouraging progress on vaccines has prompted fears over the sustainability of this market; however, we believe these fears are unwarranted,” analysts at broker finnCap (LON:FCAP) said last month.

“We believe the market has yet to peak and will do so in 2021, but will remain strong into 2022 and beyond. Overall, it is likely that COVID-19 will be a part of our lives for years to come and may even be a perpetual presence – and as long as this remains the case, COVID-19 testing will be an important tool for keeping the disease in check and avoiding outbreaks.”
Quick facts: Novacyt

70.357 Posts, Pagina: « 1 2 3 4 5 6 ... 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 ... 3514 3515 3516 3517 3518 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 19 apr 2024 17:35
Koers 0,830
Verschil +0,080 (+10,67%)
Hoog 0,867
Laag 0,735
Volume 1.517.074
Volume gemiddeld 170.336
Volume gisteren 1.093.529

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront